Terms: = Thyroid cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH
953 results:
1. Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
Han J; Gao J; Chen D; Du M; Wu Y; Ma X; Xie M; Han H; Wu C; Xue X
Clin Respir J; 2024 Apr; 18(4):e13750. PubMed ID: 38616354
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
[TBL] [Abstract] [Full Text] [Related]
3. Cytomorphology of monomorphic spindle epithelial tumor with thymus-like elements: A case with local recurrence after subtotal resection.
Arshia A; Balikani L; Booth CN
Diagn Cytopathol; 2024 Jun; 52(6):E134-E144. PubMed ID: 38520309
[TBL] [Abstract] [Full Text] [Related]
4. Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy.
Takahara Y; Abe R; Sumito N; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T
Thorac Cancer; 2024 Apr; 15(12):987-993. PubMed ID: 38485287
[TBL] [Abstract] [Full Text] [Related]
5. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
Terada K; Menju T; Date H; Haga H; Yoshizawa A
Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
7. Discrepancies Between Morphological and Immunohistochemical Classifications Are Associated With Prognoses and Subtypes of Lung cancer.
Natsume K; Ye J; Mukai Y; Yamakawa K; Tanimoto M; Ito H; Miyagi Y; Daigo Y; Muto-Ishizuka M; Kadota K; Haba R; Suizu F
Anticancer Res; 2024 Feb; 44(2):711-722. PubMed ID: 38307593
[TBL] [Abstract] [Full Text] [Related]
8. "All in one" nanoprobe Au-ttf-1 for target FL/CT bioimaging, machine learning technology and imaging-guided photothermal therapy against lung adenocarcinoma.
Yang Z; Zhang Y; Tang L; Yang X; Song L; Shen C; Zvyagin AV; Li Y; Yang B; Lin Q
J Nanobiotechnology; 2024 Jan; 22(1):22. PubMed ID: 38184620
[TBL] [Abstract] [Full Text] [Related]
9. ttf-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
Schallenberg S; Dernbach G; Dragomir MP; Schlachtenberger G; Boschung K; Friedrich C; Standvoss K; Ruff L; Anders P; Grohé C; Randerath W; Merkelbach-Bruse S; Quaas A; Heldwein M; Keilholz U; Hekmat JK; Rückert C; Büttner R; Horst D; Klauschen F; Frost N
Eur J Cancer; 2024 Jan; 197():113474. PubMed ID: 38100920
[TBL] [Abstract] [Full Text] [Related]
10. Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants.
Ohishi Y; Nakanishi Y; Hirotani Y; Suzuki A; Tanino T; Nishimaki-Watanabe H; Kobayashi H; Nozaki F; Ohni S; Tang X; Hayashi K; Nakagawa Y; Shimizu T; Tsujino I; Takahashi N; Gon Y; Masuda S
Thorac Cancer; 2024 Jan; 15(1):89-93. PubMed ID: 38093515
[TBL] [Abstract] [Full Text] [Related]
11. Liver Mass as First-Time Diagnosis of Sarcomatoid Anaplastic thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
Kamashki A; Rivera M; Sturgis CD
Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
[TBL] [Abstract] [Full Text] [Related]
12. [Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid gland].
Abrosimov AY; Bondarenko EV; Pastuhova DA; Beloshitsky ME
Arkh Patol; 2023; 85(6):47-51. PubMed ID: 38010638
[TBL] [Abstract] [Full Text] [Related]
13. Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study.
Nakamoto S; Shien T; Itoh M; Yamamoto Y; Ohsumi S; Yoshitomi S; Hikino H; Miyoshi K; Notsu A; Taira N; Doihara H; Ikeda M
Clin Exp Med; 2023 Dec; 23(8):5129-5138. PubMed ID: 37904008
[TBL] [Abstract] [Full Text] [Related]
14. Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With thyroid cancer.
Roh YH; Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
Korean J Radiol; 2023 Oct; 24(10):1028-1037. PubMed ID: 37793671
[TBL] [Abstract] [Full Text] [Related]
15. thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
[TBL] [Abstract] [Full Text] [Related]
16. Immunoreactivity of ttf-1, GATA-3, CEA, and p16/Ki67 cocktail in Cellprep®-processed control samples: Comparison of long-term storage in vials and slides.
Ryu A; Honma K; Umeno Y; Uefuji F; Muramatsu T; Nishimura S; Tanada S; Yamamoto T; Nagata S; Yamasaki T; Ohue M
Diagn Cytopathol; 2024 Jan; 52(1):3-9. PubMed ID: 37740615
[TBL] [Abstract] [Full Text] [Related]
17. Suprasellar masquerader: Chordoid glioma.
Bhardwaj N; Salunke P; Singla N; Ahuja C; Gendle C; Gupta K
Clin Neuropathol; 2024; 43(1):23-28. PubMed ID: 37675487
[TBL] [Abstract] [Full Text] [Related]
18. The role of thyroid transcription factor-1 in differentiating lung adenocarcinomas from non-pulmonary adenocarcinoma effusions.
Khidir LS; Abdelwadoud ME; Abdelmola A; Babiker NE; Elemam IB; Elmahi OM; Alharthi NS; Waggiallah HA
J Med Life; 2023 Jun; 16(6):932-936. PubMed ID: 37675165
[TBL] [Abstract] [Full Text] [Related]
19. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Bersanelli M; Cortellini A; Leonetti A; Parisi A; Tiseo M; Bordi P; Michiara M; Bui S; Cosenza A; Ferri L; Giudice GC; Testi I; Rapacchi E; Camisa R; Vincenzi B; Caruso G; Rauti AN; Arturi F; Tucci M; Santo V; Ricozzi V; Burtet V; Sgargi P; Todeschini R; Zustovich F; Stucci LS; Santini D; Buti S
Cancer Immunol Immunother; 2023 Nov; 72(11):3707-3716. PubMed ID: 37638980
[TBL] [Abstract] [Full Text] [Related]
20. Incidental thyroid Tissue in Sentinel Nodes From Oral Squamous Cell Carcinoma.
Schilling C; Collins L; Farrow A; McGurk M; Bisase B; Kerawala C; Wan S; Hall G; Thavaraj S
Laryngoscope; 2024 Mar; 134(3):1278-1281. PubMed ID: 37610258
[TBL] [Abstract] [Full Text] [Related]
[Next]
